These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 15497754)

  • 21. Eudragit-coated dextran microspheres of 5-fluorouracil for site-specific delivery to colon.
    Rai G; Yadav AK; Jain NK; Agrawal GP
    Drug Deliv; 2016; 23(1):328-37. PubMed ID: 24845476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of 5-fluorouracil and its penetration into pancreatic juice in dogs.
    Zhu Z; Fu Q; Nightingale CH; Zhao YP; Liao Q; Wang HN; Xue CQ; Yang ZY; Li DK
    Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):7-9. PubMed ID: 10375748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and characterization of new liver targeting 5-fluorouracil-cholic acid conjugates.
    Qian S; Wu JB; Wu XC; Li J; Wu Y
    Arch Pharm (Weinheim); 2009 Sep; 342(9):513-20. PubMed ID: 19598290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatic arterial infusion in the treatment of liver metastases with PEG liposomes in combination with degradable starch microspheres (DSM) increases tumor 5-FU concentration. an animal study in CC-531 liver tumor-bearing rats.
    Pohlen U; Reszka R; Buhr HJ; Berger G
    Anticancer Res; 2011 Jan; 31(1):147-52. PubMed ID: 21273592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a 5-fluorouracil-loaded PLGA microsphere delivery system by a solid-in-oil-in-hydrophilic oil (S/O/hO) novel method for the treatment of tumors.
    Lin Q; Cai Y; Yuan M; Ma L; Qiu M; Su J
    Oncol Rep; 2014 Dec; 32(6):2405-10. PubMed ID: 25231485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-FU uptake in liver metastases after intravenous and intraperitoneal administration: an autoradiographic study in the rat.
    Mahteme H; Larsson BS; Sundin A; Graf W
    Anticancer Res; 1998; 18(2A):943-9. PubMed ID: 9615745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparison of targeting distribution of two kinds of fluorouracil magnetic albumin microspheres in colorectal neoplasm nude mice in vivo under magnetic field].
    Liu ZC; Liu JG; Kong X; Jiang T; Gu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Jun; 15(6):622-4. PubMed ID: 22736137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation and characterization of lung-targeting ceftiofur-loaded gelatin microspheres.
    Hao Z; Qu B; Wang Y; Tang S; Wang G; Qiu M; Zhang R; Liu Y; Xiao X
    Drug Dev Ind Pharm; 2011 Dec; 37(12):1422-8. PubMed ID: 21635137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo biodistribution for tumor targeting of 5-fluorouracil (5-FU) loaded N-succinyl-chitosan (Suc-Chi) nanoparticles.
    Yan C; Gu J; Guo Y; Chen D
    Yakugaku Zasshi; 2010 Jun; 130(6):801-4. PubMed ID: 20519858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Slow release properties and liver-targeting characteristics of methotrexate erythrocyte carriers.
    Yuan SH; Ge WH; Huo J; Wang XH
    Fundam Clin Pharmacol; 2009 Apr; 23(2):189-96. PubMed ID: 19298236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Development of 5-fluorouracil incorporated in microspheres for peritoneal carcinomatosis--animal experiments].
    Hagiwara A; Takahashi T; Shimotsuma M; Shirasu M; Tsujimoto H; Ohyama T; Ohgaki M; Imanishi T; Yamazaki J; Fujita T
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1638-40. PubMed ID: 7574781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Solid tumor chemotherapy and in vivo distribution of fluorouracil following administration in poly(L-lactic acid) microspheres.
    Ciftci K; Hincal AA; Kas HS; Ercan TM; Sungur A; Guven O; Ruacan S
    Pharm Dev Technol; 1997 May; 2(2):151-60. PubMed ID: 9552441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Influence of the stratum corneum and dermis of the skin on the percutaneous absorption of fluorouracil delivered through skin patch].
    Li GF; Chen JH; Kamiyama F; Yamamoto A; Chen ZL
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Sep; 22(9):800-2. PubMed ID: 12297435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intra-aortal therapy with 5-fluorouracil- polyethylene glycol stealth liposomes: does the metabolism of 5-fluorouracil into 5-fluoro-2'-deoxyuridine depend on ph value?. An animal study in VX-2 liver tumor-bearing rabbits.
    Pohlen U; Binnenhei M; Reszka R; Buhr HJ; Berger G
    Chemotherapy; 2004 Jun; 50(2):67-75. PubMed ID: 15211080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A 5-fluorouracil-loaded floating gastroretentive hollow microsphere: development, pharmacokinetic in rabbits, and biodistribution in tumor-bearing mice.
    Huang Y; Wei Y; Yang H; Pi C; Liu H; Ye Y; Zhao L
    Drug Des Devel Ther; 2016; 10():997-1008. PubMed ID: 27042001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Tumor regression in long-term follow-up by administration of liposome encapsulated 5-FU. An animal experiment in WAF rats with CC-531 liver tumor].
    Pohlen U; Berger G; Jung M; Rezska R; Regenstein J; Buhr HJ
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):625-9. PubMed ID: 14518330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase I/II trial of intraperitoneal 5-Fluorouracil with and without intravenous vasopressin in non-resectable pancreas cancer.
    Oman M; Lundqvist S; Gustavsson B; Hafström LO; Naredi P
    Cancer Chemother Pharmacol; 2005 Dec; 56(6):603-9. PubMed ID: 16047145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective delivery of 5-fluorouracil (5-FU) to i.p. tissues using 5-FU microspheres in rats.
    Hagiwara A; Sakakura C; Tsujimoto H; Imanishi T; Ohgaki M; Yamasaki J; Sawai K; Takahashi T; Fujita T; Yamamoto A; Muranishi S; Ikada Y
    Anticancer Drugs; 1997 Feb; 8(2):182-8. PubMed ID: 9073314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5-fluorouracil pharmacokinetics predicts disease-free survival in patients administered adjuvant chemotherapy for colorectal cancer.
    Di Paolo A; Lencioni M; Amatori F; Di Donato S; Bocci G; Orlandini C; Lastella M; Federici F; Iannopollo M; Falcone A; Ricci S; Del Tacca M; Danesi R
    Clin Cancer Res; 2008 May; 14(9):2749-55. PubMed ID: 18451241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo distribution of 5-Fluorouracil after peritumoral implantation using a biodegradable micro-device in tumor-bearing mice.
    Zheng N; Zhou M; Lu W
    Eur J Drug Metab Pharmacokinet; 2013 Sep; 38(3):183-90. PubMed ID: 23179563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.